SCHEMBL8831162

SCHEMBL8831162

COC(=O)CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O

nearest known ligand 0.77

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.77
▸ LGALS8 O00214 1/20 0.61
▸ LGALS3 P17931 1/20 0.61
▸ LGALS4 P56470 1/20 0.61
▸ ALDH1A1 P00352 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ B4GALT1 P15291 1/20 0.48
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CD69 Q07108 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10488268 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL10488275 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL7148929 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL11423436 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL7148934 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL11423427 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL10488267 1.00 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL24997334 0.99 MAPK1 (0.74) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL15592306 0.99 MAPK1 (0.74) MAPK1LGALS8LGALS3LGALS4ALDH1A1
SCHEMBL7148656 0.91 MAPK1 (0.77) MAPK1LGALS8LGALS3LGALS4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5654412-A CONVERGENT SYNTHESIS VIA TWO DISACCHARIDE SUBCOMPONENTS; SIMPLIFICATION, HIGH YIELD GLYCOMED INCORPORATED (US) 1997-08-05 — — US disclosed
US-5646123-A Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen ALBERTA RESEARCH COUNCIL (CA) 1997-07-08 — — US disclosed
US-5580858-A Immunosuppressive and tolerogenic modified Lewisx compounds ALBERTA RESEARCH COUNCIL (CA) 1996-12-03 — — US disclosed
EP-0650492-A1 REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS ALBERTA RESEARCH COUNCIL (CA) 1995-05-03 — — EP disclosed
EP-0591254-A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?X AND LEWIS?A COMPOUNDS GLYCOMED INCORPORATED (US) 1994-04-13 — — EP disclosed
WO-1993024505-A1 REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS ALBERTA RESEARCH COUNCIL (CA) 1993-12-09 — — WO disclosed
WO-1992022564-A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISX AND LEWISA COMPOUNDS ALBERTA RESEARCH COUNCIL (CA) 1992-12-23 — — WO disclosed
US-4238473-A LOWER CARBOHYDRATES HAVING A BRIDGING ARM GLYCOSIDICALLY LINKED TO AN ALDOSE MOIETY CHEMBIOMED LIMITED (CA) 1980-12-09 — — US disclosed
US-4137401-A Glycoside-ether-ester compounds CHEMBIOMED LIMITED (CA) 1979-01-30 — — US disclosed
Send feedback